CleanSpace Holdings Limited (CSX.AX)
AUD 0.4
(-8.05%)
AUD 0.4
(-8.05%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -3.12 Million AUD | 61.54% |
| 2023 | -8.13 Million AUD | 27.92% |
| 2022 | -11.28 Million AUD | -199.07% |
| 2021 | 11.38 Million AUD | 92.28% |
| 2020 | 5.92 Million AUD | 656.44% |
| 2019 | -1.06 Million AUD | 2.95% |
| 2018 | -1.09 Million AUD | 44.85% |
| 2017 | -1.98 Million AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -536.51 Thousand AUD | 0.0% |
| 2024 Q1 | -1.02 Million AUD | 69.68% |
| 2024 FY | -3.12 Million AUD | 61.54% |
| 2024 Q2 | -2.05 Million AUD | -100.0% |
| 2024 Q3 | -536.51 Thousand AUD | 73.88% |
| 2023 Q4 | -3.38 Million AUD | -100.0% |
| 2023 FY | -8.13 Million AUD | 27.92% |
| 2023 Q3 | -1.69 Million AUD | 64.3% |
| 2023 Q2 | -4.74 Million AUD | -100.0% |
| 2023 Q1 | -2.37 Million AUD | 59.84% |
| 2022 Q4 | -5.9 Million AUD | -100.0% |
| 2022 Q1 | -2.68 Million AUD | -62.65% |
| 2022 FY | -11.28 Million AUD | -199.07% |
| 2022 Q3 | -2.95 Million AUD | 45.03% |
| 2022 Q2 | -5.37 Million AUD | -100.0% |
| 2021 Q1 | 6.51 Million AUD | -9.41% |
| 2021 Q4 | -1.65 Million AUD | -100.0% |
| 2021 Q3 | -825.98 Thousand AUD | -106.33% |
| 2021 Q2 | 13.03 Million AUD | 100.0% |
| 2021 FY | 11.38 Million AUD | 92.28% |
| 2020 Q4 | 7.19 Million AUD | 100.0% |
| 2020 Q2 | -1.27 Million AUD | -100.0% |
| 2020 FY | 5.92 Million AUD | 656.44% |
| 2020 Q1 | -637.15 Thousand AUD | 0.0% |
| 2020 Q3 | 3.59 Million AUD | 382.37% |
| 2019 FY | -1.06 Million AUD | 2.95% |
| 2018 FY | -1.09 Million AUD | 44.85% |
| 2017 FY | -1.98 Million AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 91.308% |
| Adherium Limited | -10.22 Million AUD | 69.414% |
| Aroa Biosurgery Limited | -9.74 Million AUD | 67.921% |
| Atomo Diagnostics Limited | -6.84 Million AUD | 54.334% |
| Anteris Technologies Ltd | -67.33 Million AUD | 95.356% |
| Control Bionics Limited | -5.91 Million AUD | 47.121% |
| CardieX Limited | -6.76 Million AUD | 53.777% |
| Compumedics Limited | -338 Thousand AUD | -825.19% |
| Cochlear Limited | 356.8 Million AUD | 100.876% |
| Cyclopharm Limited | -4.7 Million AUD | 33.476% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -14.564% |
| Nova Eye Medical Limited | -8.79 Million AUD | 64.424% |
| HeraMED Limited | -6.78 Million AUD | 53.902% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | 86.179% |
| ImpediMed Limited | -19.79 Million AUD | 84.198% |
| InhaleRx Limited | -1.44 Million AUD | -116.67% |
| LBT Innovations Limited | -3.74 Million AUD | 16.387% |
| Micro-X Limited | -9.76 Million AUD | 67.976% |
| Neurotech International Limited | -5.06 Million AUD | 38.312% |
| OncoSil Medical Limited | -11.91 Million AUD | 73.752% |
| PolyNovo Limited | 5.26 Million AUD | 159.44% |
| Respiri Limited | -7.12 Million AUD | 56.136% |
| SomnoMed Limited | -12.24 Million AUD | 74.455% |
| Universal Biosensors, Inc. | -6.74 Million AUD | 53.614% |
| Uscom Limited | -2.07 Million AUD | -50.724% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | 38.239% |